SCHEMBL6680502

SCHEMBL6680502

CCNCC(O)c1cccc(C#N)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 3/20 0.63
LMNA P02545 2/20 0.63
GALR3 O60755 1/20 0.63
KMT2A Q03164 1/20 0.46
KDM4E B2RXH2 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ADRB2 P07550 2/20 0.43
ADRB1 P08588 2/20 0.43
ADRB3 P13945 2/20 0.43
TSHR P16473 2/20 0.43
HTR1A P08908 1/20 0.43
ADRA2A P08913 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43
NFKB1 P19838 1/20 0.43
DRD1 P21728 1/20 0.43
HTR7 P34969 1/20 0.43
ADRA1A P35348 1/20 0.43
ADRA1B P35368 1/20 0.43
DRD3 P35462 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6666064 0.84 HIF1A (0.61) HIF1ALMNAGALR3KMT2AKDM4E
SCHEMBL9646909 0.82 LMNA (0.52) HIF1ALMNAGALR3S1PR1GRM4
SCHEMBL9706046 0.82 TSHR (0.58) HIF1ALMNAKMT2AKDM4EADRB2
SCHEMBL14535391 0.81 FAAH (0.45) HIF1ALMNAGALR3KDM4EL3MBTL1
SCHEMBL9647484 0.81 HIF1A (0.49) HIF1ALMNAGALR3KMT2AKDM4E
SCHEMBL10606401 0.81 ADRB2 (0.50) HIF1ALMNAKMT2AKDM4EADRB2
SCHEMBL12056784 0.80 GRM4 (0.44) TSHRNFKB1DRD3S1PR1GRM4
SCHEMBL19707534 0.78 GRM4 (0.43) KDM4EDRD3S1PR1GRM4
Etilefrine SCHEMBL150802 0.78 HIF1A (1.00) HIF1ALMNAGALR3KMT2AKDM4E
Etilefrine SCHEMBL30510958 0.78 HIF1A (1.00) HIF1ALMNAGALR3KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004022568-A1 ARYL-ETHANOLAMINE DERIVATIVES AS ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-18 WO disclosed